Cargando…

Enhanced inhibition of tumor growth using TRAIL-overexpressing adipose-derived stem cells in combination with the chemotherapeutic agent CPT-11 in castration-resistant prostate cancer

BACKGROUND: This study investigated the inhibition of tumor growth in castrate-resistant prostate cancer (CRPC)-bearing mice by tumor necrosis factor–related apoptosis-inducing ligand (TRAIL)-overexpressing adipose-derived stem cells (ADSCs) (hTERT-ADSC.sTRAIL), which was enhanced by combined treatm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Jae Heon, Oh, Eunjung, Han, Yong Seok, Lee, Sang Hun, Song, Yun Seob
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Asian Pacific Prostate Society 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053698/ https://www.ncbi.nlm.nih.gov/pubmed/33912512 http://dx.doi.org/10.1016/j.prnil.2020.07.002

Ejemplares similares

Carboxyl Esterase-TRAIL Expressing Human Adipose Stem Cells Inhibit Tumor Growth in Castration-Resistant Prostate Cancer-Bearing Mice with Less Toxicity
por: Kim, Jae Heon, et al.
Publicado: (2022)

Prolonged Deleterious Influences of Chemotherapeutic Agent CPT-11 on Resident Peritoneal Macrophages and B1 Cells
por: Bai, Wen-Jing, et al.
Publicado: (2018)

CPT1A Supports Castration-Resistant Prostate Cancer in Androgen-Deprived Conditions
por: Joshi, Molishree, et al.
Publicado: (2019)

Treatment of adult T-cell leukaemia-lymphoma with irinotecan hydrochloride (CPT-11). CPT-11 Study Group on Hematological Malignancy.
por: Tsuda, H., et al.
Publicado: (1994)

Pharmacological Correlation between Total Drug Concentration and Lactones of CPT‐11 and SN‐38 in Patients Treated with CPT‐11
por: Sasaki, Yasutsuna, et al.
Publicado: (1995)

Nobiletin enhances the efficacy of chemotherapeutic agents in ABCB1 overexpression cancer cells
por: Ma, Wenzhe, et al.
Publicado: (2015)

Novel agents in the management of castration resistant prostate cancer
por: Chaturvedi, Shruti, et al.
Publicado: (2014)

Evaluation of Chemotherapeutic Agents
por: Engstrom, W. W.
Publicado: (1949)

Irinotecan (CPT-11) Treatment Induces Mild Gonadotoxicity
por: Levi, Mattan, et al.
Publicado: (2022)

On the Trail of Agent Orange
por: Tenenbaum, DJ
Publicado: (2003)

WHI-P154 enhances the chemotherapeutic effect of anticancer agents in ABCG2-overexpressing cells
por: Zhang, Hui, et al.
Publicado: (2014)

Cetuximab enhanced the efficacy of chemotherapeutic agent in ABCB1/P-glycoprotein-overexpressing cancer cells
por: Wang, Fang, et al.
Publicado: (2015)

SAT024 Contribution of 11-Ketotestosterone and 11-Ketodihydrotestosterone to Castration-Resistant Prostate Cancer
por: Abu-Lebdeh, Haitham S, et al.
Publicado: (2023)

Effect of CPT‐11 on Lipid Peroxide Level in Mouse Tissues
por: Sadzuka, Yasuyuki, et al.
Publicado: (1997)

Molecular Basis of Prostate Cancer and Natural Products as Potential Chemotherapeutic and Chemopreventive Agents
por: Bai, Bingke, et al.
Publicado: (2021)

Phenotype plasticity and altered sensitivity to chemotherapeutic agents in aggressive prostate cancer cells
por: Paxson, Allan I., et al.
Publicado: (2023)

A phase II trial of combination of CPT-11 and cisplatin for advanced non-small-cell lung cancer. CPT-11 Lung Cancer Study Group.
por: Masuda, N., et al.
Publicado: (1998)

Overexpression of α (1,6) fucosyltransferase in the development of castration-resistant prostate cancer cells
por: Höti, Naseruddin, et al.
Publicado: (2018)

Surgical castration efficiently delays the time of starting a systemic chemotherapy in castration-resistant prostate cancer patients refractory to initial androgen-deprivation therapy
por: Kang, Minyong, et al.
Publicado: (2015)

Relationship between Development of Diarrhea and the Concentration of SN‐38, an Active Metabolite of CPT‐11, in the Intestine and the Blood Plasma of Athymic Mice Following Intraperitoneal Administration of CPT‐11
por: Araki, Eiji, et al.
Publicado: (1993)

Statins reduce castration-induced bone marrow adiposity and prostate cancer progression in bone
por: Pan, Tianhong, et al.
Publicado: (2021)

Progress in treatment of small-cell lung cancer: role of CPT-11
por: Saijo, N
Publicado: (2003)

11-Ketotestosterone is the predominant active androgen in prostate cancer patients after castration
por: Snaterse, Gido, et al.
Publicado: (2021)

CPT and Superstring
por: Ellis, John R., et al.
Publicado: (1996)

Castration for Prostatic Hypertrophy
Publicado: (1899)

ZRSR2 overexpression is a frequent and early event in castration-resistant prostate cancer development
por: He, Haiqing, et al.
Publicado: (2021)

Effect of Various Chemotherapeutic Agents on Metastasis
por: Lapis, K., et al.
Publicado: (1956)

Accidental Overdose of Multiple Chemotherapeutic Agents
por: Kim, In Soon, et al.
Publicado: (1989)

Nail Changes Induced by Chemotherapeutic Agents
por: Saraswat, Neerja, et al.
Publicado: (2020)

Anesthesia Medications and Interaction with Chemotherapeutic Agents
por: Watson, Jeremy, et al.
Publicado: (2021)

Rociletinib (CO-1686) enhanced the efficacy of chemotherapeutic agents in ABCG2-overexpressing cancer cells in vitro and in vivo
por: Zeng, Fanpu, et al.
Publicado: (2020)

Prostate Tumor Overexpressed-1 (PTOV1) promotes docetaxel-resistance and survival of castration resistant prostate cancer cells
por: Cánovas, Verónica, et al.
Publicado: (2017)

Prognostic Value of Body Mass Index in Korean Patients with Castration-Resistant Prostate Cancer
por: Park, Jeong Min, et al.
Publicado: (2012)

The Use of Androgen Deprivation Therapy (ADT) and Chemotherapeutic Agents in New Zealand Men with Prostate Cancer
por: Lawrenson, Ross, et al.
Publicado: (2014)

Impact of diverse chemotherapeutic agents and external factors on activation of brown adipose tissue in a large patient collective
por: Brendle, Cornelia, et al.
Publicado: (2019)

11-Ketotestosterone and 11-Ketodihydrotestosterone in Castration Resistant Prostate Cancer: Potent Androgens Which Can No Longer Be Ignored
por: Pretorius, Elzette, et al.
Publicado: (2016)

Combination of long-acting TRAIL and tumor cell-targeted photodynamic therapy as a novel strategy to overcome chemotherapeutic multidrug resistance and TRAIL resistance of colorectal cancer
por: She, Tianshan, et al.
Publicado: (2021)

Determinants of CPT-11 and SN-38 activities in human lung cancer cells.
por: van Ark-Otte, J., et al.
Publicado: (1998)

Effect of antivascular endothelial growth factor treatment on the intratumoral uptake of CPT-11
por: Wildiers, H, et al.
Publicado: (2003)

Irinotecan (CPT-11) Chemotherapy Alters Intestinal Microbiota in Tumour Bearing Rats
por: Lin, Xiaoxi B., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_j1j78kce878p08v4u0f9ajgok9